APO Research

APO RESEARCH · REPORT

Bovine Mastitis

Selected research

Market Outlook & Growth Opportunities

Global Bovine Mastitis Market Outlook and Growth Opportunities 2026

Market perspective

The global Bovine Mastitis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bovine Mastitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bovine Mastitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bovine Mastitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bovine Mastitis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bovine Mastitis market include Zoetis, Bayer, West Way Health, MSD Animal Health, Elanco, Ceva and Boehringer Ingelheim International, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bovine Mastitis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bovine Mastitis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bovine Mastitis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bovine Mastitis market.

Bovine Mastitis Segment by Company

Zoetis

Bayer

West Way Health

MSD Animal Health

Elanco

Ceva

Boehringer Ingelheim International

Bovine Mastitis Segment by Type

Antibiotics

Others

Bovine Mastitis Segment by Application

Lactating Period

Dry Period

Bovine Mastitis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bovine Mastitis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bovine Mastitis key companies, revenue, market share, and recent developments.

3. To split the Bovine Mastitis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bovine Mastitis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bovine Mastitis significant trends, drivers, influence factors in global and regions.

6. To analyze Bovine Mastitis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Mastitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Mastitis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Mastitis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bovine Mastitis industry.

Chapter 3: Detailed analysis of Bovine Mastitis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bovine Mastitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bovine Mastitis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bovine Mastitis Industry Trends Table 2. Bovine Mastitis Industry Drivers Table 3. Bovine Mastitis Industry Opportunities and Challenges Table 4. Bovine Mastitis Industry Restraints Table 5. Global Bovine Mastitis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bovine Mastitis Revenue Share by Company (2021-2026) Table 7. Global Bovine Mastitis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bovine Mastitis Key Company Manufacturing Base & Headquarters Table 9. Global Bovine Mastitis Company, Product Type & Application Table 10. Global Bovine Mastitis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bovine Mastitis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Antibiotics Table 15. Significant Companies of Others Table 16. Global Bovine Mastitis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Bovine Mastitis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Bovine Mastitis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Bovine Mastitis Sales Value Share by Type (2021-2026) Table 20. Global Bovine Mastitis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Lactating Period Table 22. Significant Companies of Dry Period Table 23. Global Bovine Mastitis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Bovine Mastitis Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Bovine Mastitis Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Bovine Mastitis Sales Value Share by Application (2021-2026) Table 27. Global Bovine Mastitis Sales Value Share by Application (2027-2032) Table 28. Global Bovine Mastitis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Bovine Mastitis Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Bovine Mastitis Sales Value Share by Region (2021-2026) Table 31. Global Bovine Mastitis Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Bovine Mastitis Sales Value Share by Region (2027-2032) Table 33. Global Bovine Mastitis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bovine Mastitis Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Bovine Mastitis Sales Value Market Share by Country (2021-2026) Table 36. Global Bovine Mastitis Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Bovine Mastitis Sales Value Market Share by Country (2027-2032) Table 38. Zoetis Company Information Table 39. Zoetis Business Overview Table 40. Zoetis Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Zoetis Bovine Mastitis Product Portfolio Table 42. Zoetis Recent Development Table 43. Bayer Company Information Table 44. Bayer Business Overview Table 45. Bayer Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Bayer Bovine Mastitis Product Portfolio Table 47. Bayer Recent Development Table 48. West Way Health Company Information Table 49. West Way Health Business Overview Table 50. West Way Health Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. West Way Health Bovine Mastitis Product Portfolio Table 52. West Way Health Recent Development Table 53. MSD Animal Health Company Information Table 54. MSD Animal Health Business Overview Table 55. MSD Animal Health Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. MSD Animal Health Bovine Mastitis Product Portfolio Table 57. MSD Animal Health Recent Development Table 58. Elanco Company Information Table 59. Elanco Business Overview Table 60. Elanco Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Elanco Bovine Mastitis Product Portfolio Table 62. Elanco Recent Development Table 63. Ceva Company Information Table 64. Ceva Business Overview Table 65. Ceva Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ceva Bovine Mastitis Product Portfolio Table 67. Ceva Recent Development Table 68. Boehringer Ingelheim International Company Information Table 69. Boehringer Ingelheim International Business Overview Table 70. Boehringer Ingelheim International Bovine Mastitis Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim International Bovine Mastitis Product Portfolio Table 72. Boehringer Ingelheim International Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Bovine Mastitis Product Image Figure 2. Global Bovine Mastitis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Mastitis Market Size (2021-2032) & (US$ Million) Figure 4. Global Bovine Mastitis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Antibiotics Image Figure 8. Others Image Figure 9. Global Bovine Mastitis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Bovine Mastitis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Bovine Mastitis Sales Value Share by Type (2021-2032) Figure 12. Lactating Period Image Figure 13. Dry Period Image Figure 14. Global Bovine Mastitis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bovine Mastitis Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bovine Mastitis Sales Value Share by Application (2021-2032) Figure 17. Global Bovine Mastitis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Bovine Mastitis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Bovine Mastitis Sales Value (2021-2032) & (US$ Million) Figure 20. North America Bovine Mastitis Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Bovine Mastitis Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Bovine Mastitis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Bovine Mastitis Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Bovine Mastitis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Bovine Mastitis Sales Value (2021-2032) & (US$ Million) Figure 26. South America Bovine Mastitis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Bovine Mastitis Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Bovine Mastitis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Bovine Mastitis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Bovine Mastitis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Bovine Mastitis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Others
Applications
  • Lactating Period
  • Dry Period
Companies covered
  • Zoetis
  • Bayer
  • West Way Health
  • MSD Animal Health
  • Elanco
  • Ceva
  • Boehringer Ingelheim International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bovine Mastitis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bovine Mastitis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bovine Mastitis Market Dynamics
  1. 2.1 Bovine Mastitis Industry Trends
  2. 2.2 Bovine Mastitis Industry Drivers
  3. 2.3 Bovine Mastitis Industry Opportunities and Challenges
  4. 2.4 Bovine Mastitis Industry Restraints
3 Bovine Mastitis Market by Company
  1. 3.1 Global Bovine Mastitis Company Revenue Ranking in 2025
  2. 3.2 Global Bovine Mastitis Revenue by Company (2021-2026)
  3. 3.3 Global Bovine Mastitis Company Ranking (2024-2026)
  4. 3.4 Global Bovine Mastitis Company Manufacturing Base and Headquarters
  5. 3.5 Global Bovine Mastitis Company Product Type and Application
  6. 3.6 Global Bovine Mastitis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bovine Mastitis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bovine Mastitis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bovine Mastitis Market by Type
  1. 4.1 Bovine Mastitis Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Others
  4. 4.2 Global Bovine Mastitis Sales Value by Type
  5. 4.2.1 Global Bovine Mastitis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bovine Mastitis Sales Value by Type (2021-2032)
  7. 4.2.3 Global Bovine Mastitis Sales Value Share by Type (2021-2032)
5 Bovine Mastitis Market by Application
  1. 5.1 Bovine Mastitis Application Introduction
  2. 5.1.1 Lactating Period
  3. 5.1.2 Dry Period
  4. 5.2 Global Bovine Mastitis Sales Value by Application
  5. 5.2.1 Global Bovine Mastitis Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bovine Mastitis Sales Value by Application (2021-2032)
  7. 5.2.3 Global Bovine Mastitis Sales Value Share by Application (2021-2032)
6 Bovine Mastitis Regional Value Analysis
  1. 6.1 Global Bovine Mastitis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bovine Mastitis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bovine Mastitis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bovine Mastitis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bovine Mastitis Sales Value (2021-2032)
  7. 6.3.2 North America Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bovine Mastitis Sales Value (2021-2032)
  10. 6.4.2 Europe Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bovine Mastitis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bovine Mastitis Sales Value (2021-2032)
  16. 6.6.2 South America Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bovine Mastitis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
7 Bovine Mastitis Country-level Value Analysis
  1. 7.1 Global Bovine Mastitis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bovine Mastitis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bovine Mastitis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bovine Mastitis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bovine Mastitis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bovine Mastitis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bovine Mastitis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bovine Mastitis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bovine Mastitis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bovine Mastitis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bovine Mastitis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bovine Mastitis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bovine Mastitis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bovine Mastitis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bovine Mastitis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bovine Mastitis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bovine Mastitis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bovine Mastitis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bovine Mastitis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bovine Mastitis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bovine Mastitis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bovine Mastitis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bovine Mastitis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bovine Mastitis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bovine Mastitis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bovine Mastitis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bovine Mastitis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bovine Mastitis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bovine Mastitis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bovine Mastitis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bovine Mastitis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bovine Mastitis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Bovine Mastitis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Bovine Mastitis Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Bovine Mastitis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Bovine Mastitis Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 West Way Health
  14. 8.3.1 West Way Health Company Information
  15. 8.3.2 West Way Health Business Overview
  16. 8.3.3 West Way Health Bovine Mastitis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 West Way Health Bovine Mastitis Product Portfolio
  18. 8.3.5 West Way Health Recent Developments
  19. 8.4 MSD Animal Health
  20. 8.4.1 MSD Animal Health Company Information
  21. 8.4.2 MSD Animal Health Business Overview
  22. 8.4.3 MSD Animal Health Bovine Mastitis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MSD Animal Health Bovine Mastitis Product Portfolio
  24. 8.4.5 MSD Animal Health Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Bovine Mastitis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Bovine Mastitis Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 Ceva
  32. 8.6.1 Ceva Company Information
  33. 8.6.2 Ceva Business Overview
  34. 8.6.3 Ceva Bovine Mastitis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Bovine Mastitis Product Portfolio
  36. 8.6.5 Ceva Recent Developments
  37. 8.7 Boehringer Ingelheim International
  38. 8.7.1 Boehringer Ingelheim International Company Information
  39. 8.7.2 Boehringer Ingelheim International Business Overview
  40. 8.7.3 Boehringer Ingelheim International Bovine Mastitis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boehringer Ingelheim International Bovine Mastitis Product Portfolio
  42. 8.7.5 Boehringer Ingelheim International Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research